OBSERVE MEDICAL ASA

0191 OSLO

Finances

Return on Equity

−36,73 %

Current Ratio

0,4

Debt-to-Equity Ratio

0,04

Key figures (NOK)	2022	2021	2020	2019
Revenue	19 521 000	24 042 000	2 961 000	177 000
Net Income	−50 801 000	−26 321 000	−36 869 000	−16 917 000
Total Assets	215 812 000	71 738 000	87 732 000	55 333 000
Total Equity	138 306 000	−14 122 000	20 348 000	14 542 000

Income (NOK)	2022	2021	2020	2019
Revenue	19 521 000	24 042 000	2 961 000	177 000
Expenditure	78 664 000	60 586 000	31 048 000	15 963 000
Operating Profit	−59 143 000	−36 544 000	−28 087 000	−15 787 000
Financial Income	19 122 000	15 711 000	3 853 000	365 000
Financial Costs	10 704 000	5 488 000	12 635 000	1 496 000
Financial Balance	8 418 000	10 223 000	−8 782 000	−1 131 000
Earnings Before Tax	−50 725 000	−26 321 000	−36 869 000	−16 917 000
Tax	76 000	0	0	0
Net Income	−50 801 000	−26 321 000	−36 869 000	−16 917 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	186 880 000	56 579 000	57 936 000	51 670 000
Total Current Assets	28 932 000	15 159 000	29 796 000	3 663 000
Total Assets	215 812 000	71 738 000	87 732 000	55 333 000
Total Retained Equity	124 398 000	−118 084 000	−83 614 000	−48 029 000
Total Equity	138 306 000	−14 122 000	20 348 000	14 542 000
Total Long-Term Debt	5 276 000	13 581 000	57 449 000	37 889 000
Total Current Debt	72 230 000	72 279 000	9 935 000	2 902 000
Total Equity and Debt	215 812 000	71 738 000	87 732 000	55 333 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	19 521 000	24 042 000	2 961 000	177 000
Other Income	0	0	0	0
Revenue	19 521 000	24 042 000	2 961 000	177 000
Cost of Goods Sold	14 344 000	14 524 000	1 975 000	637 000
Salary Costs	28 521 000	19 013 000	10 891 000	5 299 000
Depreciation	10 931 000	3 463 000	3 163 000	4 285 000
Impairment	0	0	0	0
Expenditure	78 664 000	60 586 000	31 048 000	15 963 000
Operating Profit	−59 143 000	−36 544 000	−28 087 000	−15 787 000
Financial Income	19 122 000	15 711 000	3 853 000	365 000
Financial Costs	10 704 000	5 488 000	12 635 000	1 496 000
Financial Balance	8 418 000	10 223 000	−8 782 000	−1 131 000
Dividends	0	0	0	0
Net Income	−50 801 000	−26 321 000	−36 869 000	−16 917 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	99 961 000	33 870 000	36 268 000	30 333 000
Total Intangible Assets	182 728 000	55 198 000	57 233 000	51 331 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	278 000
Fixtures	4 152 000	1 381 000	703 000	62 000
Total Tangible Assets	4 152 000	1 381 000	703 000	339 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	186 880 000	56 579 000	57 936 000	51 670 000
Stock	8 117 000	7 013 000	7 661 000	2 504 000
Total Investments	0	0	0	0
Cash, Bank	13 641 000	2 864 000	18 945 000	485 000
Total Current Assets	28 932 000	15 159 000	29 796 000	3 663 000
Total Assets	215 812 000	71 738 000	87 732 000	55 333 000
Total Equity	138 306 000	−14 122 000	20 348 000	14 542 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	5 276 000	13 581 000	57 449 000	37 889 000
Creditors	8 610 000	6 163 000	3 843 000	1 338 000
Unpaid Taxes	6 074 000	3 747 000	2 348 000	499 000
Dividends	0	0	0	0
Other Current Debt	57 495 000	55 860 000	3 744 000	1 064 000
Total Current Debt	72 230 000	72 279 000	9 935 000	2 902 000
Total Equity and Debt	215 812 000	71 738 000	87 732 000	55 333 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−36,73 %	186,38 %	−181,19 %	−116,33 %
Debt-to-Equity Ratio	0,04	−0,96	2,82	2,61
Operating Profit Margin	−302,97 %	−152 %	−948,56 %	−8 919,21 %
Current Ratio	0,4	0,21	3	1,26
Quick Ratio	0,45	0,23	13,1	9,2
Equity Ratio	0,64	−0,2	0,23	0,26
Gross Profit Margin	26,52 %	39,59 %	33,3 %	−259,89 %